We have previously shown that endogenous Insulin-like growth factor-I (IGF-I) regulates growth of human intestinal smooth muscle cells by stimulating proliferation and inhibiting apoptosis. In active Crohn's disease, expression of IGF-I and the αVβ3 integrin receptor ligands, fibronectin and vitronectin are increased. The aim of the present study was to determine whether occupation of the αVβ3 receptor influences IGF-I receptor tyrosine kinase activation and function in human intestinal smooth muscle cells.
INTRODUCTION
Integrins are a family of transmembrane proteins comprised of 18 α-subunits and 8 β-subunits which heterodimerize to form the 24 known integrin pairs (9). A wide variety of integrin ligands have been described that bind to specific integrins and together participate in outside-in and inside-out integrin signaling (17) . While integrin expression, in general, is widespread throughout the body, the expression of specific integrins and their preferred ligands is tissue specific. This confers one level of specificity to an otherwise ubiquitously expressed family of proteins and is fundamental to their ability to regulate cellular events. Smooth muscle of visceral and vascular types express the α1β1, α5β1, αVβ3, α2β1, α3β1, α5β1, αVβ1, αVβ5, and α1β6 integrins (28). Unlike receptors with intrinsic tyrosine kinase-containing activity, in response to their ligands, integrin receptors undergo a conformational change that changes their activation state (5) .
Phosphorylation of cytoplasmic domains of integrin β-subunits results in the association of signaling proteins (25; 36).
Experimental evidence in cells that were detached and reattached to extracellular matrix proteins has shown that integrins can modulate growth-factor stimulated receptor activation and thereby regulate growth-factor stimulated cell adhesion and cell motility (38). Clemmons et al have shown that in porcine vascular smooth muscle, αVβ3 integrin (the cognate vitronectin receptor), modulates IGF-I-stimulated smooth muscle motility and proliferation in stably attached cells in vitro without being subjected to detachment and reattachment (7; 37). The αVβ3 integrin also has been shown to play a key role in the regulation of IGF-I-mediated vascular smooth muscle growth during atheroma formation in vivo (29) . The muscle hyperplasia that accompanies atheroma development G-00345-2005.R1 and contributes to arterial narrowing can be prevented by a neutralizing antibody to αVβ3 integrin (29). Integrin and IGF-I modulated uterine smooth muscle growth has also been implicated as a factor in leiomyoma formation (4; 33).
In cultured porcine vascular smooth muscle cells, three transmembrane proteins: the αVβ3 integrin, tyrosine phosphatase SHP-2 substrate 1 (SHPS-1) and the IGF-I receptor tyrosine kinase jointly regulate cellular responses to IGF-I (8). Acting in concert these three proteins regulate the recruitment of the SH2 domain-containing protein tyrosine phosphatase, SHP-2, to the IGF-I receptor tyrosine kinase (27) . Interplay between the αVβ3 integrin and growth factor receptors is a common theme and its modulation of PDGF, VEGF, and insulin signaling has been demonstrated (32). The EGF receptor has been shown to interact directly with α5β1, α6β4, and αVβ1 integrins (13) . The activation of PDGF, FGF, insulin and EGF receptor tyrosine kinases, in addition to the IGF-I receptor tyrosine kinase, are modulated by the protein tyrosine phosphatase SHP-2.
Patients with active Crohn's Disease have elevated plasma levels of fibronectin, a ligand of αVβ3 integrin (2) . In regions of inflammation and stricturing, the numbers of mast cells resident in the muscularis propria are higher than in the muscle layer of uninflamed intestine. Although immunoreactive laminin co-localized with markers of tissue mast cells, immunoreactive fibronectin or vitronectin did not (14) . Neither the expression of αVβ3 integrin and of its ligands, fibronectin and vitronectin, by intestinal smooth muscle, nor the role of this system in regulating muscle cells proliferation in response to IGF-I have been examined.
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Kuemmerle-6 This paper shows that human intestinal smooth muscle cells express the αV and β3 integrin subunits and the αVβ3 integrin ligands, vitronectin and fibronectin in vivo.
Expression of all four remains constant when intestinal smooth muscle cells are cultured.
IGF-I stimulates time-dependent phosphorylation of the IGF-I receptor tyrosine kinase, recruitment and phosphorylation of insulin receptor substrate-1 (IRS-1), and the downstream kinases Erk1/2 and p70S6 kinase phosphorylation which jointly stimulate muscle cell proliferation (20) . SH2-domain containing protein tyrosine phosphatase, SHP-2, is recruited in a time-dependent fashion to the activated IGF-I receptor tyrosine kinase. SHP-2 recruitment coincides in time with dephosphorylation of the IGF-I receptor tyrosine kinase. The αVβ3 integrin ligand, fibronectin, augments IGF-I-stimulated IGF-I receptor tyrosine kinase phosphorylation, Erk1/2 and p70S6 kinase phosphorylation and proliferation. In contrast, the αVβ3 selective antagonist, echistatin, diminished IGF-I stimulated IGF-I receptor phosphorylation, recruitment and phosphorylation of IRS-1, phosphorylation of Erk1/2 and p70S6 kinase and muscle cell proliferation. The rate of IGF-I stimulated SHP-2 recruitment to the IGF-I receptor in the presence of echistatin was accelerated. The results implied that activation state of αVβ3 integrin is regulated by endogenous integrin ligands and modulates IGF-I stimulated receptor activation, signaling pathways and proliferation in human intestinal smooth muscle cells.
The potential clinical significance of this mechanism has relevance in the setting of chronic intestinal inflammation when levels of the αVβ3 integrin ligands, vitronectin and fibronectin, are increased and could act in concert with the observed increased IGF-I levels that augment intestinal muscle cell proliferation and inhibition of apoptosis leading to hyperplasia of the muscularis propria and stricture formation.
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METHODS
Culture of Smooth Muscle Cells Isolated from Normal Human Jejunum. Muscle cells were isolated and cultured from the circular muscle layer of human jejunum as described previously (19; 20) . Briefly, 4-5 cm segments of normal intestine were obtained from patients undergoing surgery according to a protocol approved by the VCU Institutional Review Board. After opening the segments along the mesenteric border, the mucosa was dissected away and the remaining muscle layer cut into 2X2 cm strips.
Slices were obtained separately from the circular layer using a Stadie-Riggs tissue slicer.
The slices were incubated overnight at 37°C in 20 ml of Dulbecco's modification of Eagle's medium plus 10% fetal bovine serum (DMEM-10) containing penicillin 200U/ml, streptomycin 200 µg/ml, gentamycin 100µg/ml and amphotericin B 2 µg/ml to which was added 0.0375% collagenase (type II), and 0.1% soybean trypsin inhibitor.
Muscle cells dispersed from the circular layer were harvested by filtration through 500 µm Nitex mesh and centrifugation at 150 g for 5 minutes. Cells were resuspended and washed twice by centrifugation at 150g for 5 min. After resuspension in DMEM-10 containing the same antibiotics, the cells were plated at a concentration of 5x10 5 cells per ml as determined by counting in a hemocytometer. Cultures were incubated in a 10%
CO 2 environment at 37°C. DMEM-10 medium was replaced every three days until the cells reached confluence.
Primary cultures of muscle cells were passaged upon reaching confluence and used in first passage. We have previously shown that these cells express a phenotype characteristic of intestinal smooth muscle as determined by immunostaining for smooth muscle markers (clone HM 19/2, 5 µg/ml) and expression of γ-enteric actin (34). Immunoprecipitation of IGF-I receptor. IGF-I receptors were immunoprecipitated as previously described (21) . Briefly, confluent smooth muscle cells were rendered quiescent by incubation in serum-free DMEM for 24 h. Cells were incubated with the αVβ3 integrin ligand, fibronectin (5 µg/cm 2 cultureware surface area), the αVβ3 selective disintegrin, echistatin (100 nM) or vehicle for the final 12 h (7). Cells were then stimulated with 100 nM IGF-I for periods of time from 0 -30 min. The reaction was terminated by washing twice with ice-cold PBS. Cell lysates were prepared in an immunoprecipitation buffer consisting of (in mM): 50 Tris-HCl (pH 7.5), 150 NaCl, 50
NaF, 1 Na orthovanadate, 1 dithiothreitol, 1 phenylmethylsulfonyl fluoride and 0.5% NP-40 to which was added 1 µg/ml leupeptin, 1 µg/ml pepstatin A, and 1 µg/ml aprotinin.
The resulting lysates were clarified by centrifugation at 14,000g for 10 min at 4°C. The lysates were pre-cleared by incubation with Protein A agarose beads for 1 h at 4°C.
Samples containing equal amounts of protein (1 mg) were incubated for 2 h at 4°C with 2 µg of rabbit anti-IGF-IR β-subunit. The incubation continued overnight at 4°C after the addition of 10 µl of Protein A agarose beads. The immune complex-agarose beads were washed three times with ice-cold immunoprecipitation buffer and twice with ice-cold kinase assay buffer. After washing the immune complex-agarose beads were resuspended in 25 µl sample buffer, boiled for 5 min, and then loaded onto a 7.5%
polyacrylamide gel and the proteins separated by SDS-PAGE. Tyrosine phosphorylated We have previously shown that IGF-I is an autocrine growth factor of human intestinal smooth muscle cells (19) . The present paper shows that the αV and β3 integrin subunits and the αVβ3 ligands, vitronectin and fibronectin, are expressed by these cells. 
